Trials / Unknown
UnknownNCT01089244
FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma
Molecular Correlates and Clinical Significance of Positron Emission Tomography With FET-PET in Combination With Perfusion-weighted Magnetic Resonance Imaging (PWI) in Patients With Low Grade Gliomas
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 38 (actual)
- Sponsor
- Ludwig-Maximilians - University of Munich · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to compare the two imaging modalities perfusion weighted MR-imaging and FET-PET in their ability to provide an accurate histological evaluation of low grade glioma and to reveal focal abnormalities within a homogeneously appearing tumor. Additionally, therapeutic effects should be assessed during a time period of two years.
Conditions
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2010-03-18
- Last updated
- 2015-09-22
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01089244. Inclusion in this directory is not an endorsement.